$1.35
0.075.47%
Last update: Nov 9, 9:30 AM
Autolus Therapeutics PLC
AUTLNASDAQ
The average analyst price target for Autolus Therapeutics is $9.14, 577.0% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $4.80 to $13. The latest change came on Nov 2, 2026, when HC Wainwright & Co. assumed coverage of Autolus Therapeutics with a Buy rating and a $10 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
